Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1396640-59-7
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of rezafungin during breastfeeding. Because rezafungin is about 90% bound to plasma proteins and has poor oral bioavailability, it is unlikely to reach the milk and be absorbed by the infant. If rezafungin is required by the mother, it is not a reason to discontinue breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Rezafungin
CAS Registry Number
1396640-59-7
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Micafungin.[Drugs and Lactation Database (...]Review Micafungin.. Drugs and Lactation Database (LactMed®). 2006
- Regulatory Considerations in the Approval of Rezafungin (REZZAYO) for the Treatment of Candidemia and Invasive Candidiasis in Adults.[J Infect Dis. 2024]Regulatory Considerations in the Approval of Rezafungin (REZZAYO) for the Treatment of Candidemia and Invasive Candidiasis in Adults.Smith HL, Bensman TJ, Mishra S, Li X, Dixon CA, Sheikh J, McMaster OG, Joshi A, Rubin DB, Goodwin A, et al. J Infect Dis. 2024 Mar 19; . Epub 2024 Mar 19.
- Review Caspofungin.[Drugs and Lactation Database (...]Review Caspofungin.. Drugs and Lactation Database (LactMed®). 2006
- Review Zuranolone.[Drugs and Lactation Database (...]Review Zuranolone.. Drugs and Lactation Database (LactMed®). 2006
- Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy.[J Glob Antimicrob Resist. 2018]Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy.Sofjan AK, Mitchell A, Shah DN, Nguyen T, Sim M, Trojcak A, Beyda ND, Garey KW. J Glob Antimicrob Resist. 2018 Sep; 14:58-64. Epub 2018 Feb 24.
- Rezafungin - Drugs and Lactation Database (LactMed®)Rezafungin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...